Rankings
▼
Calendar
MNKD Q1 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$841M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+403.5% YoY
Gross Profit
$12M
68.2% margin
Operating Income
-$14M
-77.5% margin
Net Income
-$15M
-85.3% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+8.8%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$999,000
Balance Sheet
Total Assets
$101M
Total Liabilities
$289M
Stockholders' Equity
-$188M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$3M
+403.5%
Gross Profit
$12M
-$543,000
+2289.9%
Operating Income
-$14M
-$27M
+49.6%
Net Income
-$15M
-$30M
+51.0%
Revenue Segments
Product
$5M
100%
← FY 2019
All Quarters
Q2 2019 →